Zhang Financial LLC trimmed its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 4.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,187 shares of the medical equipment provider’s stock after selling 100 shares during the period. Zhang Financial LLC’s holdings in Align Technology were worth $396,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of ALGN. Buckingham Capital Management Inc. grew its position in Align Technology by 9.1% in the first quarter. Buckingham Capital Management Inc. now owns 3,883 shares of the medical equipment provider’s stock worth $1,104,000 after acquiring an additional 323 shares in the last quarter. Rehmann Capital Advisory Group boosted its holdings in shares of Align Technology by 160.2% during the 1st quarter. Rehmann Capital Advisory Group now owns 229 shares of the medical equipment provider’s stock worth $65,000 after buying an additional 141 shares during the period. Horizon Investments LLC bought a new stake in shares of Align Technology during the 1st quarter worth $229,000. Amundi Pioneer Asset Management Inc. boosted its holdings in shares of Align Technology by 6.1% during the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 189,285 shares of the medical equipment provider’s stock worth $53,819,000 after buying an additional 10,916 shares during the period. Finally, WINTON GROUP Ltd boosted its holdings in shares of Align Technology by 43.5% during the 2nd quarter. WINTON GROUP Ltd now owns 2,640 shares of the medical equipment provider’s stock worth $723,000 after buying an additional 800 shares during the period. 88.31% of the stock is owned by institutional investors.
In other news, Director Andrea Lynn Saia sold 4,157 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $179.54, for a total value of $746,347.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Vamsi Mohan Raj Pudipeddi acquired 1,100 shares of the company’s stock in a transaction dated Tuesday, August 6th. The stock was acquired at an average price of $188.11 per share, with a total value of $206,921.00. Following the purchase, the vice president now owns 1,100 shares in the company, valued at approximately $206,921. The disclosure for this purchase can be found here. Over the last three months, insiders sold 44,157 shares of company stock valued at $7,976,448. Insiders own 1.30% of the company’s stock.
Align Technology stock traded up $0.33 during mid-day trading on Friday, reaching $214.25. The company had a trading volume of 717,880 shares, compared to its average volume of 1,168,789. The company has a quick ratio of 1.74, a current ratio of 1.85 and a debt-to-equity ratio of 0.04. Align Technology, Inc. has a 52 week low of $169.84 and a 52 week high of $334.64. The company has a 50 day moving average of $184.00 and a 200-day moving average of $249.74. The firm has a market cap of $16.71 billion, a price-to-earnings ratio of 43.55, a PEG ratio of 1.72 and a beta of 2.00.
Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.13. Align Technology had a net margin of 19.06% and a return on equity of 29.26%. The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $599.86 million. During the same period in the prior year, the firm earned $1.30 EPS. The business’s revenue was up 22.5% on a year-over-year basis. On average, analysts predict that Align Technology, Inc. will post 5 earnings per share for the current fiscal year.
Align Technology Company Profile
Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontics, and restorative and aesthetic dentistry worldwide. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as compliance indicators and compensation for tooth eruption; Invisalign Assist treatment, which offers support to dental practitioners throughout the treatment process, including progress tracking; and Invisalign First Phase I and Invisalign First Comprehensive Phase II package for younger patients with early mixed dentition with a mixture of primary/baby and permanent teeth.
Further Reading: What is Call Option Volume?
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.